Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions

NCT ID: NCT02365376

Last Updated: 2015-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this protocol is to enable collection of biospecimens to facilitate current and future multidisciplinary research in rare genetic disorders and medical conditions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rare Genetic Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willing and able to provide written, signed informed consent
* Willing and able to comply with all study procedures

Exclusion Criteria

* Use of any investigational product or investigational medical device within 30 days prior to screening, except as part of a BioMarin-sponsored study
* Concurrent disease or condition that would interfere with study participation or safety.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BioMarin Pharmaceutical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Evelyn Wang

Role: CONTACT

415-506-6818

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BMN 000-901

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

FaceBase Biorepository
NCT01252264 COMPLETED
Reverse Phenotyping Core
NCT03632239 ENROLLING_BY_INVITATION
Genetic Collection Protocol
NCT05272319 RECRUITING
Tissue Sample Study for Mitochondrial Disorders
NCT01803906 ENROLLING_BY_INVITATION
Idiopathic Diseases of Man
NCT01440218 ENROLLING_BY_INVITATION